Results 51 to 60 of about 8,842 (142)
Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa
JEADV Clinical Practice, Volume 5, Issue 2, Page 648-650, June 2026.ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori +2 more
wiley +1 more source
Management of epidermolysis bullosa simplex in pregnancy: A case report
Case Reports in Women's Health, 2019 Epidermolysis bullosa (EB) encompasses a group of diseases characterized by extreme fragility of skin and mucous membranes, resulting in blister formation following minimal injury.
Nidhi Shah +2 more
doaj +1 more source
Modern methods of the treatment of hereditary epidermolysis bullosa
Vestnik Dermatologii i Venerologii, 2017 Today there are no ethiopathogenetic treatment methods for treating hereditary epidermolysis bullosa. All available treatment methods are symptomatic and are mainly aimed at patient care.
A. A. Kubanov +3 more
doaj +1 more source
JEADV Clinical Practice, Volume 5, Issue 2, Page 656-660, June 2026.Capsule Summary Bruxism and sweat‐induced facial blisters can affect patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) quality of life (QoL). We present the outcomes of orofacial BTX‐A infiltrations to treat these conditions. Three patients with severe RDEB, bruxism and microstomia received BTX‐A infiltrations (50U‐100U) in masseters and ...
Susanne Krämer +4 more
wiley +1 more source
A pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa
BMC Medical GenomicsDystrophic epidermolysis bullosa is a rare subtype of inherited epidermolysis bullosa, caused by variants in the collagen type VII alpha 1 chain (COL7A1) gene (MIM120120).
Saira Sattar +6 more
doaj +1 more source
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page e569-e574, July 2026.
S. Benkimoun +14 more
wiley +1 more source
Hematology, Transfusion and Cell TherapyIntroduction: Secondary thrombocytosis is a well-recognized response to chronic inflammation, infections, and systemic disorders, but its association with dermatologic diseases such as Norwegian scabies and epidermolysis bullosa is rare.
Mine Ezgi Payaslı +3 more
doaj +1 more source
Australian Veterinary Journal, Volume 104, Issue 6, Page 356-364, June 2026.Pyrexia is a non‐specific clinical sign associated with many diseases in dogs. This case series examines the final diagnoses, breed distribution and outcomes in dogs aged 18 months or under with pyrexia >24 h duration. Medical record databases of 11 Australian emergency and referral hospitals between 1st January 2020 and 31st January 2025 were searched
H Lobegeier +3 more
wiley +1 more source
Real‐World Experience With Oleogel‐S10 for Wounds in Epidermolysis Bullosa
JEADV Clinical PracticeBackground Oleogel‐S10 is the first approved drug for the treatment of wounds in patients with junctional and dystrophic epidermolysis bullosa. Results from the clinical trials, early access programme and open‐label study are available, showing good ...
Miodrag Davidovic +2 more
doaj +1 more source
From Hair to Healing: Follicular Unit Transplantation for Chronic Ulcer Management—A Case Series
International Wound Journal, Volume 23, Issue 6, June 2026.ABSTRACT Scalp follicular unit (FU) transplantation is a highly effective yet underutilised minimally invasive technique for promoting healing in chronic and recalcitrant cutaneous wounds. In this case series, five patients with long‐standing nonhealing leg ulcers of mixed etiologies were treated exclusively with single FU grafts harvested from the ...
Francisco Jimenez +4 more
wiley +1 more source